Gabelli & Co Investment Advisers’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Gabelli & Co Investment Advisers's ATEX Position: Q1 2026 in Review
Gabelli & Co Investment Advisers sold out of Anterix (ATEX) in Q1 2026, closing a stake of 30,650 shares — an estimated $669K sold.
Gabelli & Co Investment Advisers first reported a position in ATEX in Q2 2025 and held it in 3 quarters. The position peaked at $1.12M in Q3 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Gabelli & Co Investment Advisers reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
- Gabelli & Co Investment Advisers sold 30,650 Anterix shares in Q1 2026, an estimated $669K.
- Gabelli & Co Investment Advisers first reported a position in Anterix in Q2 2025 and held it in 3 quarters.
- Gabelli & Co Investment Advisers's Anterix position peaked at $1.12M in Q3 2025.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.